Cellosaurus HCC827 GR5 (CVCL_V622)
Cell line name | HCC827 GR5 |
---|---|
Synonyms | HCC827-GR5; HCC-827-GR5; HCC827GR5 |
Accession | CVCL_V622 |
Resource Identification Initiative | To cite this cell line use: HCC827 GR5 (RRID:CVCL_V622) |
Comments | Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). Population: Caucasian. Doubling time: 48 hours (PubMed=25984343). Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa). Omics: Deep exome analysis. Omics: shRNA library screening. Derived from site: In situ; Lung; UBERON=UBERON_0002048. |
Sequence variations |
|
Disease | Lung adenocarcinoma (NCIt: C3512) |
Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
Hierarchy | Parent: CVCL_2063 (HCC827) |
Sex of cell | Female |
Age at sampling | 39Y |
Category | Cancer cell line |
Publications | PubMed=17463250; DOI=10.1126/science.1141478 PubMed=20716641; DOI=10.1158/1535-7163.MCT-10-0481; PMCID=PMC3208321 PubMed=25984343; DOI=10.1038/sdata.2014.35; PMCID=PMC4432652 PubMed=31068700; DOI=10.1038/s41586-019-1186-3; PMCID=PMC6697103 |
Cross-references | |
Cell line databases/resources | cancercelllines; CVCL_V622
Cell_Model_Passport; SIDM01636 DepMap; ACH-000029 |
Biological sample resources | BioSample; SAMN10988418 |
Chemistry resources | PharmacoDB; HCC827GR5_462_2019 |
Encyclopedic resources | Wikidata; Q54881790 |
Gene expression databases | GEO; GSM466322 |
Polymorphism and mutation databases | Progenetix; CVCL_V622 |
Entry history | |
Entry creation | 16-Apr-2014 |
Last entry update | 05-Oct-2023 |
Version number | 19 |